摘要
目的研究和厚朴酚(honokiol,HNK)对结肠癌SW620细胞的增殖抑制作用及其机制。方法采用结晶紫染色法、流式细胞术和Western blot等检测HNK抑制结肠癌SW620细胞增殖的作用,以及HNK对TGF-β1表达的影响;采用Western blot分析HNK对p38 MAPK磷酸化的影响,以及HNK联合应用过表达TGF-β1腺病毒与TGF-β1抑制剂对p38 MAPK磷酸化的影响;Western blot分析HNK对YAP磷酸化的影响,并分析HNK磷酸化p38 MAPK的作用与YAP的可能关系。结果HNK对SW620细胞增殖具有抑制作用,并能上调TGF-β1的蛋白表达;同时,HNK可以上调SW620细胞中p38 MAPK的磷酸化;过表达TGF-β1腺病毒能够促进p38 MAPK的磷酸化,而TGF-β1抑制剂能够抑制结论HNK能够抑制SW620细胞的增殖,其作用机制可能是通过上调TGF-β1并激活p38 MAPK信号通路来促进YAP磷酸化。
Aim To investigate the molecular mechanisms and inhibitory effect of honokiol(HNK)on the proliferation of colon cancer SW620 cells.Methods Crystal violet staining,flow cytometry and Western blot assays were used to for the detection of the effect of HNK on inhibiting the proliferation and promoting apoptosis on SW620 cells.Western blot was used to study the effect of HNK on the protein levels of TGF-β1 and analyze the effect of HNK on the phosphorylation of p38 MAPK,as well as the effect of HNK combined with exogenous adenoviruses of TGF-β1 and its inhibitor on the phosphorylation of p38 MAPK in SW620 cells.Western blot was also used to analyze the effect of HNK on the phosphorylation of YAP and analyze the possible relationship between HNK phosphorylation of p38 MAPK and YAP.Results HNK significantly inhibited the proliferation of SW620 cells and induced apoptosis,and up-regulated the expression levels of TGF-β1.Western blotting showed that HNK up-regulated the expression levels of phosphorylated p38 in SW620 cells.Meanwhile,HNK increased the protein levels of phosphorylated YAP.The exogenous adenoviruses of TGF-β1 and its inhibitor significantly enhanced or inhibited this effect,respectively.Conclusions HNK has obvious antiproliferative effect,which might be due to the up-regulation of TGF-β1 expression and up-regulation of phosphorylated YAP expression by activating the p38 MAPK signaling pathway.
作者
刘晓璐
马妍
刘荣兴
李沁
孙文娟
何百成
LIU Xiao-lu;MA Yan;LIU Rong-xing;LI Qin;SUN Wen-juan;HE Bai-cheng(Chongqing Key Lab of Biochemistry and Molecular Pharmcology,Chongqing 400016,China;Dept of Pharmacology,Pharmacy School,Chongqing Medical University,Chongqing 400016,China;Dept of Pharmacology,School of Basic Medical Sciences,Wuhan University,Wuhan 430072,China)
出处
《中国药理学通报》
CAS
CSCD
北大核心
2021年第11期1577-1584,共8页
Chinese Pharmacological Bulletin
基金
国家自然科学基金资助项目(No81572226)。